🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/12/2001 | 64,20 | 64,20 | 62,50 | 63,21 | -2,06% | 2,65% | 7.216.947 |
| 04/12/2001 | 65,36 | 65,43 | 63,93 | 64,53 | -1,27% | 2,29% | 4.667.058 |
| 03/12/2001 | 64,07 | 65,36 | 63,79 | 65,36 | +1,11% | 2,46% | 5.402.964 |
| 30/11/2001 | 63,93 | 65,01 | 63,93 | 64,65 | +1,35% | 1,69% | 5.919.838 |
| 29/11/2001 | 63,07 | 63,83 | 62,83 | 63,79 | +2,30% | 1,57% | 5.056.810 |
| 28/11/2001 | 63,65 | 63,90 | 62,26 | 62,36 | -1,86% | 2,58% | 4.634.990 |
| 27/11/2001 | 63,98 | 64,77 | 62,98 | 63,54 | -0,69% | 2,80% | 5.263.475 |
| 26/11/2001 | 62,83 | 64,90 | 62,75 | 63,98 | +1,70% | 3,42% | 6.490.054 |
| 23/11/2001 | 62,58 | 63,10 | 62,02 | 62,91 | +0,53% | 1,72% | 2.452.530 |
| 21/11/2001 | 61,20 | 62,61 | 61,12 | 62,58 | +2,25% | 2,45% | 4.760.750 |
| 20/11/2001 | 61,07 | 61,64 | 60,97 | 61,20 | -0,70% | 1,09% | 5.740.525 |
| 19/11/2001 | 61,55 | 61,68 | 60,83 | 61,63 | -0,48% | 1,38% | 7.126.819 |
| 16/11/2001 | 62,21 | 62,40 | 61,12 | 61,93 | +0,37% | 2,06% | 5.739.686 |
| 15/11/2001 | 61,99 | 62,55 | 61,58 | 61,70 | -0,35% | 1,55% | 5.424.029 |
| 14/11/2001 | 61,91 | 62,52 | 61,36 | 61,92 | +0,48% | 1,87% | 5.106.170 |
| 13/11/2001 | 61,48 | 62,08 | 60,83 | 61,62 | +0,31% | 2,03% | 6.104.810 |
| 12/11/2001 | 61,16 | 61,83 | 60,59 | 61,43 | -0,36% | 2,03% | 4.527.674 |
| 09/11/2001 | 62,21 | 62,77 | 61,50 | 61,65 | -0,94% | 2,04% | 3.435.973 |
| 08/11/2001 | 61,88 | 62,78 | 61,62 | 62,23 | +0,74% | 1,87% | 4.401.286 |
| 07/11/2001 | 62,44 | 63,11 | 61,50 | 61,77 | -1,07% | 2,58% | 4.094.431 |
| 06/11/2001 | 61,64 | 62,61 | 61,17 | 62,44 | +0,09% | 2,32% | 4.829.603 |
| 05/11/2001 | 62,53 | 63,18 | 62,18 | 62,39 | +0,54% | 1,60% | 4.201.013 |
| 02/11/2001 | 61,07 | 62,26 | 61,07 | 62,05 | +1,29% | 1,95% | 4.358.527 |
| 01/11/2001 | 60,89 | 61,93 | 60,52 | 61,26 | +0,61% | 2,32% | 5.825.832 |
| 31/10/2001 | 61,77 | 61,98 | 60,88 | 60,89 | -1,45% | 1,79% | 4.336.729 |
| 30/10/2001 | 62,04 | 62,17 | 61,05 | 61,78 | -0,74% | 1,80% | 4.206.777 |
| 29/10/2001 | 62,50 | 63,04 | 62,17 | 62,24 | -0,87% | 1,40% | 3.185.710 |
| 26/10/2001 | 63,41 | 63,42 | 62,60 | 62,79 | -1,04% | 1,29% | 4.195.878 |
| 25/10/2001 | 63,36 | 64,21 | 62,29 | 63,44 | -0,76% | 3,03% | 4.859.366 |
| 24/10/2001 | 63,17 | 64,69 | 63,13 | 63,93 | +0,07% | 2,48% | 4.010.486 |